11 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

SYNCHRON SYSTEMS CREATININE REAGENT

FDA 510(k)
FDA Class 2 ·Clinical Chemistry

LIFEMATE HEMOFILTRATION SYSTEM

FDA 510(k)
FDA Class 2 ·Gastroenterology, Urology

MONOJECT PREFILL 0.9% SODIUM CHLORIDE FLUSH SYRINGE

FDA 510(k)
FDA Class 2 ·General Hospital

PROSPACE PEEK IMPLANT 5 7X8X22MM

FDA Adverse Event
Malfunction ·AESCULAP AG AND CO. KG·Product code MAX·June 21, 2013

TSPACE PEEK IMPLANT 26X11X7MM

FDA Adverse Event
Malfunction ·AESCULAP IMPLANT SYSTEMS·Product code MAX·October 30, 2015

VITROS CHEMISTRY PRODUCTS GENT REAGENT

FDA Adverse Event
Malfunction ·ORTHO-CLINICAL DIAGNOSTICS·Product code LCD·July 17, 2012

COOK DIALYSIS CATHETER

FDA Adverse Event
Injury ·BARD MEDICAL DIVISION·Product code MSD·April 11, 2013

EEA 31MM SINGLE-USE STAPLER

FDA Adverse Event
Injury ·COVIDIEN, FORMERLY USSC PUERTO RICO, INC.·Product code GDW·September 5, 2014

SYNCHROMED EL

FDA Adverse Event
Injury ·RICE CREEK MANUFACTURING·Product code LKK·July 8, 2008

Stryker MA204 Bed Model (FL25E) Beds are intended for medical purposes in both general patient care as well as critical care environments. Each uses built-in electric motors and controls which can be operated by the patient, or caregiver, to adjust the height and/or surface contour of the bed.The devices listed above also include movable and latchable side rails which can be lowered or raised to help prevent patient fall and subsequent injury. The Beds include an optional Scale (Models: FL20E, FL25E, FL28C, FL28EX) as well as an optional Bed Exit (1 Zone) or Chaperone

FDA Enforcement
Class II ·Terminated·Stryker Medical Division of Stryker Corporation·July 4, 2012

cobas 6000 Modular Series system; Part Numbers: 1. 04745914001 cobas c 501 module; 2. 05036453001 cobas 6000 UL c 501 + Core Fix configuration; 3. 05036453692 - cobas 6000 UL + CORE CU; and 4. 05860636001 cobas 6000 c 501 (UL) V

FDA Enforcement
Class II ·Terminated·Roche Diagnostics Corporation·March 14, 2018